Literature DB >> 9608407

Effectiveness of ECT in patients with parkinsonism.

C Moellentine1, T Rummans, J E Ahlskog, W S Harmsen, V J Suman, M K O'Connor, J L Black, T Pileggi.   

Abstract

Electroconvulsive therapy (ECT) has been used to treat the psychiatric complications of Parkinson's disease. Concurrent improvement of parkinsonian motor symptoms has been noted. This retrospective study compared the outcomes of 25 patients with parkinsonism receiving ECT for psychiatric indications with outcomes of 25 patients (matched for age and gender) without neurological disease also receiving ECT for psychiatric indications. Significant improvement in psychiatric symptoms was noted following ECT for both groups. No differences in efficacy of ECT were found between the two groups. Fourteen of the 25 patients with Parkinson's symptoms were noted to have at least transient improvement in motor function at discharge. ECT is an effective treatment for patients with parkinsonism and psychiatric comorbidity.

Entities:  

Mesh:

Year:  1998        PMID: 9608407     DOI: 10.1176/jnp.10.2.187

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  24 in total

Review 1.  Neuropsychiatric aspects of Parkinson's disease.

Authors:  D Aarsland; K Karlsen
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  Neuropsychiatric phenomena associated with movement disorders.

Authors:  Joshua L Roffman; Todd Eisenberg; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

Review 3.  Recognition and management of neuropsychiatric complications in Parkinson's disease.

Authors:  Florian Ferreri; Catherine Agbokou; Serge Gauthier
Journal:  CMAJ       Date:  2006-12-05       Impact factor: 8.262

Review 4.  Anxiety in Parkinson's disease: identification and management.

Authors:  Jack J Chen; Laura Marsh
Journal:  Ther Adv Neurol Disord       Date:  2014-01       Impact factor: 6.570

5.  Effectiveness of Electroconvulsive Therapy (ECT) in Parkinsonian Symptoms: A Case Series.

Authors:  Sandeep Grover; Aditya Somani; Neeru Sahni; Sahil Mehta; Swati Choudhary; Rahul Kumar Chakravarty; Anju Moni Rabha
Journal:  Innov Clin Neurosci       Date:  2018-02-01

6.  Evaluation and management of the non-motor features of Parkinson's disease.

Authors:  Steven Wishart; Graeme J A Macphee
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

Review 7.  Psychiatric aspects of Parkinson's disease--an update.

Authors:  Anette Schrag
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

Review 8.  Current Methods for the Treatment and Prevention of Drug-Induced Parkinsonism and Tardive Dyskinesia in the Elderly.

Authors:  Carlos Estevez-Fraga; Paul Zeun; Jose Luis López-Sendón Moreno
Journal:  Drugs Aging       Date:  2018-11       Impact factor: 3.923

Review 9.  Neuropsychiatric symptoms in Parkinson's disease.

Authors:  Dag Aarsland; Laura Marsh; Anette Schrag
Journal:  Mov Disord       Date:  2009-11-15       Impact factor: 10.338

10.  [Depression in Parkinson's disease. Assessment and treatment].

Authors:  S Brand; R Dodel; M Hautzinger; G Gründer; A Althaus; F Schneider
Journal:  Nervenarzt       Date:  2007-06       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.